Stephen Chan

19.2k citations
194 papers · 11.2k · 3 hit papers · h-index 47

Impact in

  • Oncology top 0.1%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 57
    • HER2/EGFR in Cancer Research 42
    • Cancer-related Molecular Pathways 14
    • DNA Repair Mechanisms 27

Stephen Chan

187 papers receiving 10.9k citations

Stephen Chan's Hit Papers

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer 2011 · 766 citations
7660+7+14Years since publication50010001.5k2.0k

Peers

Stephen Chan
Comparison fields: 5 of 133
  • Oncology 7.5k
  • Cancer Research 2.7k
  • Radiology, Nuclear Medicine and Imaging 1.8k
  • Pulmonary and Respiratory Medicine 2.6k
  • Genetics 661
Replace Luc Dirix with:
Luc Dirix Belgium
Ahmad Awada Belgium
Jean-­Marc Ferrero France
Robert L. Camp United States
Angelo Di Leo Italy
Joan Albanell Spain
Virginia Paton United States
Fabio Puglisi Italy
Anthony W. Tolcher United States
Aurélien Marabelle France
Stephen Chan relative to Luc Dirix Belgium Luc Dirix's profile →
Citations per field
00.5×1.5×
Luc Dirix · 1×
Citations per year

Countries citing papers authored by Stephen Chan

Since Specialization
Citations

This map shows the geographic impact of Stephen Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Chan more than expected).

Fields of papers citing papers by Stephen Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Chan. The network helps show where Stephen Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Chan Line = papers co-authored together Stephen Chan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Hit paper breakdown →
20062498
2
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
Hit paper breakdown →
20051162
3
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Hit paper breakdown →
2011766
4 2005386
5 2003290
6 2008268
7 2004246
8 2013199
9 2008164
10 2003153
11 2004135
12 2004128
13 2004121
14 2000118
15 2010117
16 2004114
17 2010111
18 2003110
19 2011102
20 200694

About Stephen Chan

Stephen Chan is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 194 papers that have together received 11.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (57 papers), HER2/EGFR in Cancer Research (42 papers), Breast Cancer Treatment Studies (37 papers), DNA Repair Mechanisms (27 papers), Ovarian cancer diagnosis and treatment (16 papers), Advanced Breast Cancer Therapies (16 papers), Estrogen and related hormone effects (14 papers) and Cancer-related Molecular Pathways (14 papers). The work is most often cited by research in Oncology (7.5k citations), Cancer Research (2.7k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Genetics (661 citations). Stephen Chan has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Tadeusz Pieńkowski, John Crown, Arlene Chan, Cristina Oliva, Mark S. Berger, Mario Campone, David Cameron, Charles E. Geyer, Stephen D. Rubin and Deborah Lindquist. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Breast Cancer Research and Treatment, Annals of Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact